Protein kinase inhibitors in melanoma

Author： Eigentler Thomas K Meier Friedegund Garbe Claus

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.16, 2013-11, pp. : 2195-2201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Irreversible Protein Kinase Inhibitors

Current Medicinal Chemistry, Vol. 18, Iss. 20, 2011-07 ,pp. : 2981-2994

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinase inhibitors: breakthrough medicines and the next generation

By Sawyer Tomi K

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 675-678

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase inhibitors against malignant lymphoma

By D'Cruz Osmond J Uckun Fatih M

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 707-721

Informa Healthcare

Access to resources Recommend Favorite

Protein kinase CK2 inhibitors: a patent review

By Cozza Giorgio Pinna Lorenzo A Moro Stefano

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1081-1097

Informa Healthcare

Access to resources Recommend Favorite

Protein Kinase Inhibitors for the Treatment of Inflammation - An Overview

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 1, 2007-02 ,pp. : 3-4

Bentham Science Publishers

Access to resources Recommend Favorite